Table 1. Autoantibodies associated with cutaneous manifestations in idiopathic inflammatory myopathies (IIM)*.
Autoantibody |
Antigen Target |
Associated Clinical Phenotype |
Associated Cutaneous Features |
Anti-Mi-2 |
Nuclear helicase |
Reduced risk of interstitial lung disease, better response to therapy with fewer flares, overall good prognosis |
Heliotrope rash, Gottron’s papules, V-and shawl-sign rashes, cuticular overgrowth |
Anti-synthetase (anti-Jo-1, anti-PL-7, anti-PL-12, anti-EJ, anti-OJ, anti-KS, anti-Zo, others) |
Aminoacyl tRNA synthetase |
Fever, polyarthritis, interstitial lung disease, moderate to severe myositis; good response to corticosteroid therapy, but flare after tapering, less favorable prognosis |
Mechanic’s hands, Raynaud’s |
Anti-PM-Scl |
PM-Scl complex, comprising 11-16 nucleolar polypeptides |
Overlap with scleroderma, risk of pulmonary/renal disease |
En coup de sabre, beak-like facies, severe Raynaud’s, and sclerodactyly |
Anti-p155 |
155 kD protein preliminarily identified as transcriptional intermediary factor 1 gamma |
Common in adult and juvenile DM, malignancy associated DM , overlap myositis in DM , decreased risk of interstitial lung disease |
Skin ulceration, erythroderma, edema, generalized lipodystrophy, V- and shawl-sign rashes, Gottron’s papules |
Anti-CADM-140 |
140 kD protein of unknown specificity |
Amyopathic DM, increased risk of interstitial lung disease |
“Classic cutaneous features of DM”—Heliotrope rash, Gottron’s papules |
Anti-MJ |
140 kD protein preliminarily identified as nuclear matrix protein NXP-2 |
Juvenile DM |
Calcinosis |
*Abbreviations: IIM, idiopathic inflammatory myopathy; DM, dermatomyositis